Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HROW Harrow Health Inc
- Stocks
- Healthcare
- NASDAQ: HROW
Price (delayed)
$23.59
Market cap
$841.08M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.49
Enterprise value
$1.02B
Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton
Highlights
HROW's gross profit has soared by 66% YoY and by 23% QoQ
HROW's revenue has surged by 53% year-on-year and by 18% since the previous quarter
Harrow Health's quick ratio has increased by 35% from the previous quarter but it has decreased by 26% YoY
Harrow Health's debt has increased by 18% YoY and by 17% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.harrowinc.com
Key stats
What are the main financial stats of HROW
Market
Valuations
Earnings
Shares outstanding
35.65M
Market cap
$841.08M
Enterprise value
$1.02B
Price to earnings (P/E)
N/A
Price to book (P/B)
12.06
Price to sales (P/S)
4.21
EV/EBIT
187.1
EV/EBITDA
51.13
EV/Sales
5.12
Revenue
$199.61M
Gross profit
$150.37M
Operating income
$8.82M
Net income
-$17.48M
EBIT
$5.47M
EBITDA
$20M
Free cash flow
-$23.8M
Per share
Balance sheet
Liquidity
EPS
-$0.49
EPS diluted
-$0.49
Free cash flow per share
-$0.67
Book value per share
$1.96
Revenue per share
$5.6
TBVPS
$5.66
Total assets
$388.97M
Total liabilities
$319.67M
Debt
$228.83M
Equity
$69.65M
Working capital
$98.31M
Debt to equity
3.29
Current ratio
2.08
Quick ratio
1.79
Net debt/EBITDA
9.08
Margins
Efficiency
Dividend
EBITDA margin
10%
Gross margin
75.3%
Net margin
-8.8%
Operating margin
4.4%
Return on assets
-5.2%
Return on equity
-28.3%
Return on invested capital
2.4%
Return on capital employed
1.8%
Return on sales
2.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HROW stock price
How has the Harrow Health stock price performed over time
Intraday
-4.07%
1 week
-5.64%
1 month
6.26%
1 year
128.59%
YTD
-29.69%
QTD
-11.32%
Financial performance
How have Harrow Health's revenue and profit performed over time
Revenue
$199.61M
Gross profit
$150.37M
Operating income
$8.82M
Net income
-$17.48M
Gross margin
75.3%
Net margin
-8.8%
Harrow Health's operating income has soared by 199% from the previous quarter
HROW's operating margin has surged by 183% since the previous quarter
HROW's gross profit has soared by 66% YoY and by 23% QoQ
Harrow Health's net margin has soared by 56% from the previous quarter and by 53% YoY
Price vs fundamentals
How does HROW's price correlate with its fundamentals
Growth
What is Harrow Health's growth rate over time
Valuation
What is Harrow Health stock price valuation
P/E
N/A
P/B
12.06
P/S
4.21
EV/EBIT
187.1
EV/EBITDA
51.13
EV/Sales
5.12
The EPS rose by 48% since the previous quarter and by 35% year-on-year
The stock's price to book (P/B) is 58% less than its 5-year quarterly average of 28.4 and 26% less than its last 4 quarters average of 16.3
Harrow Health's equity has increased by 20% from the previous quarter
HROW's revenue has surged by 53% year-on-year and by 18% since the previous quarter
HROW's P/S is 29% below its last 4 quarters average of 5.9
Efficiency
How efficient is Harrow Health business performance
The ROIC has soared by 143% from the previous quarter
The return on sales has surged by 139% since the previous quarter
The return on assets has surged by 51% since the previous quarter and by 45% year-on-year
Harrow Health's return on equity has increased by 47% QoQ and by 45% YoY
Dividends
What is HROW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HROW.
Financial health
How did Harrow Health financials performed over time
The total assets is 22% greater than the total liabilities
Harrow Health's quick ratio has increased by 35% from the previous quarter but it has decreased by 26% YoY
Harrow Health's current ratio has increased by 34% QoQ but it has decreased by 27% YoY
The debt to equity has grown by 21% YoY but it has contracted by 2.7% from the previous quarter
Harrow Health's equity has increased by 20% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.